[go: up one dir, main page]

GR3034405T3 - Synthesis of cyclic peptides - Google Patents

Synthesis of cyclic peptides

Info

Publication number
GR3034405T3
GR3034405T3 GR20000402096T GR20000402096T GR3034405T3 GR 3034405 T3 GR3034405 T3 GR 3034405T3 GR 20000402096 T GR20000402096 T GR 20000402096T GR 20000402096 T GR20000402096 T GR 20000402096T GR 3034405 T3 GR3034405 T3 GR 3034405T3
Authority
GR
Greece
Prior art keywords
synthesis
cyclic peptides
oxytocin
vasopressin
analogs
Prior art date
Application number
GR20000402096T
Other languages
English (en)
Inventor
Lars Henrik Harald Andersson
Jan-Ake Skoeldbaeck
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of GR3034405T3 publication Critical patent/GR3034405T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR20000402096T 1993-06-29 2000-09-13 Synthesis of cyclic peptides GR3034405T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8484993A 1993-06-29 1993-06-29
PCT/SE1994/000620 WO1995001368A1 (en) 1993-06-29 1994-06-22 Improved synthesis of cyclic peptides

Publications (1)

Publication Number Publication Date
GR3034405T3 true GR3034405T3 (en) 2000-12-29

Family

ID=22187613

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402096T GR3034405T3 (en) 1993-06-29 2000-09-13 Synthesis of cyclic peptides

Country Status (9)

Country Link
US (3) US5596078A (el)
EP (1) EP0710243B1 (el)
AT (1) ATE193892T1 (el)
DE (1) DE69424940T2 (el)
DK (1) DK0710243T3 (el)
ES (1) ES2149880T3 (el)
GR (1) GR3034405T3 (el)
PT (1) PT710243E (el)
WO (1) WO1995001368A1 (el)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
ATE193892T1 (de) * 1993-06-29 2000-06-15 Ferring Bv Synthese zyklischer peptide
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
EP0896001A1 (en) * 1997-08-08 1999-02-10 Daicel Chemical Industries, Ltd. Method for preparing oxytocin antagoniste derivatives, intermediates for the preparation of oxytocin antagonist derivatives and method for preparing the intermediates
CA2329130A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
EP1141011A2 (en) 1999-01-12 2001-10-10 Neorx Corporation Compounds and methods to inhibit or augment an inflammatory response
US7566765B2 (en) * 2000-03-06 2009-07-28 Rigel Pharmaceuticals, Inc. Heterocyclic compounds containing a nine-membered carbon-nitrogen ring
US20040132706A1 (en) * 2001-10-05 2004-07-08 Daniela Salvemini Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
EP2322198A2 (en) * 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
DE60305043T2 (de) * 2003-11-13 2006-11-30 Ferring B.V. Blisterverpackung und feste Dosierungsform enthaltend Desmopressin
US7729761B2 (en) 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
ATE469912T1 (de) * 2004-10-04 2010-06-15 Novetide Ltd Gegenionenaustauschverfahren für peptide
EP1810028A2 (en) * 2004-10-14 2007-07-25 Rigel Pharmaceuticals, Inc. Heterocyclic inhibitors of ires-mediated translation and methods of use thereof
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
US7960336B2 (en) 2007-08-03 2011-06-14 Pharmain Corporation Composition for long-acting peptide analogs
US8399410B2 (en) 2007-08-06 2013-03-19 Allergan, Inc. Methods and devices for desmopressin drug delivery
US8563527B2 (en) 2007-08-20 2013-10-22 Pharmain Corporation Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
CN101372504B (zh) * 2007-08-22 2011-05-18 深圳翰宇药业股份有限公司 一种纯化去氨加压素的方法
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
SI3225250T1 (sl) * 2008-05-21 2019-11-29 Ferring Bv Orodisperzibilen dezmopresin za podaljšanje začetnega obdobja spanja, ki ga ne moti nokturija
WO2010119450A2 (en) 2009-04-06 2010-10-21 Matrix Laboratories Ltd An improved process for the preparation of desmopressin or its pharmaceutically acceptable salts
MX343193B (es) 2009-06-18 2016-10-26 Allergan Inc Administracion segura de desmopresina.
AU2010339794B2 (en) 2009-12-17 2016-09-22 Children's Medical Center Corporation Saposin-A derived peptides and uses thereof
CN102127146B (zh) * 2010-12-24 2013-04-24 深圳翰宇药业股份有限公司 一种制备醋酸阿托西班的方法
EP4306123A3 (en) 2011-12-22 2024-04-17 Children's Medical Center Corporation Saposin-a derived peptides and uses thereof
WO2013172954A1 (en) 2012-05-17 2013-11-21 Ra Pharmaceuticals, Inc Peptide and peptidomimetic inhibitors
ES2872403T3 (es) 2013-03-14 2021-11-02 Childrens Medical Center Péptido Psap para el tratamiento de cánceres que expresan CD36
WO2015148801A1 (en) 2014-03-26 2015-10-01 Children's Medical Center Corporation Cyclic prosaposin peptides and uses thereof
PL3154561T3 (pl) 2014-06-12 2019-12-31 Ra Pharmaceuticals, Inc. Modulowanie aktywności dopełniacza
CN104761619A (zh) * 2015-01-06 2015-07-08 苏州天马医药集团天吉生物制药有限公司 醋酸去氨加压素的固相制备工艺
HRP20211824T1 (hr) 2015-01-28 2022-03-04 Ra Pharmaceuticals, Inc. Modulatori aktivnosti komplementa
WO2017083362A1 (en) 2015-11-09 2017-05-18 Trustees Of Tufts College Compounds and methods for treating pain
KR102429287B1 (ko) * 2015-12-10 2022-08-05 가부시끼가이샤 메니콘 펩티드 조성물
RS60134B1 (sr) 2015-12-16 2020-05-29 Ra Pharmaceuticals Inc Modulatori aktivnosti komplementa
EP3496740B1 (en) 2016-08-09 2022-05-04 Omnix Medical Ltd. A combination of antimicrobial peptides and antibiotic drugs for treating diseases
BR112019011053A2 (pt) 2016-12-07 2019-10-15 Ra Pharmaceuticals Inc moduladores da atividade do complemento
EP3956343A1 (en) 2019-04-16 2022-02-23 Bachem Holding AG Manufacture of disulfide bonded peptides
CN109929010B (zh) * 2019-05-06 2021-05-14 上海上药第一生化药业有限公司 一种加压素的精制方法
WO2022026463A1 (en) * 2020-07-27 2022-02-03 Arizona Board Of Regents On Behalf Of The University Of Arizona Oxytocin analogues and methods for using the same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4717715A (en) * 1986-06-23 1988-01-05 Smithkline Beckman Corporation ARG7 -ARG8 -vasopressin antagonists
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
DE3726324A1 (de) * 1987-08-07 1989-02-16 Hoechst Ag Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
SE502644C2 (sv) * 1990-02-27 1995-11-27 Ferring Ab Vasoaktiva vasotocinderivat
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
ATE193892T1 (de) * 1993-06-29 2000-06-15 Ferring Bv Synthese zyklischer peptide
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
HK1000906A1 (en) * 1993-06-29 2002-03-08 Ferring B.V. Compositions for nasal administration of desmopressin
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches

Also Published As

Publication number Publication date
US5596078A (en) 1997-01-21
EP0710243B1 (en) 2000-06-14
ES2149880T3 (es) 2000-11-16
US5726287A (en) 1998-03-10
DK0710243T3 (da) 2000-10-16
US5990273A (en) 1999-11-23
ATE193892T1 (de) 2000-06-15
DE69424940T2 (de) 2000-12-28
EP0710243A1 (en) 1996-05-08
WO1995001368A1 (en) 1995-01-12
DE69424940D1 (de) 2000-07-20
PT710243E (pt) 2000-11-30

Similar Documents

Publication Publication Date Title
GR3034405T3 (en) Synthesis of cyclic peptides
GR3024420T3 (en) Process for the preparation of oxetanones
EP0745610A3 (en) Process for preparing anti-obesity protein
BG106786A (en) Process for the preparation of amorphous atorvastatin
EP0872481A4 (en) DEPSIPEPTIDE DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF AND INTERMEDIATE PRODUCT THEREFOR
MY116862A (en) New processes for preparing pesticidal intermediates
BG105426A (bg) Метод за пречистване на амониев сулфат
MY106864A (en) Improved process for cyclic amino acid anticonvulsant compounds.
Alcaraz et al. Enantioselective synthesis of (+)-(1R, 2S)-allocoronamic acid
PL347070A1 (en) Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound
CA2215251A1 (en) Industrial preparation of high purity gallic acid
MY104452A (en) Processes for the preparation of morniflumate and analogous compounds.
EA199700189A1 (ru) Производные аминотетралона и способ их получения
CA2076886A1 (en) Method for production of 2-amino-6-halogenopurine and synthesis intermediate therefor
EP0161468A3 (en) Process for the solid phase synthesis of peptides which contain sulfated tyrosine
HK1000909A (en) Improved synthesis of cyclic peptides
GR3015359T3 (en) Process for the production of peptides by solid phase synthesis.
ATE30159T1 (de) Anthracyclinderivate, verfahren zu ihrer herstellung ausgehend von einem stamm von mikroorganismen, der neue stamm streptomyces cyaneus und die verwendung der anthracyclinderivate als pharmazeutische praeparate.
GB1571835A (en) Aminocyclols
AU6418096A (en) Process for separating pivalic acid from spent reaction mixtures
Andersson et al. Synthesis of cyclic peptides
ES8403110A1 (es) Un procedimiento para la preparacion de pirbuterol.
CA2361565A1 (en) Synthesis of ethyleneimine dimer
FR2406626B1 (el)
JPS6438050A (en) Novel production process